Galvanize Therapeutics, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Galvanize Therapeutics, Inc. - overview
Established
2015
Location
Redwood City, CA, US
Primary Industry
Medical Devices & Equipment
About
Founded in 2015 by founder Jonathan Waldstreicher and based in California, US, Galvanize Therapeutics, Inc. develops energy-based medical devices to address a range of medical conditions, such as oncology, chronic bronchitis, and drug delivery. In September 2025, Galvanize Therapeutics, Inc. raised USD 100 million in series C funding led by investor Sofinnova Partners, with participation from other investors Norwest Venture Partners, Elevage Medical Technologies, LP, Ally Bridge Group, Perceptive Advisors, Janus Henderson Investors, Longaeva Partners, Fidelity Investments, T Rowe Price, Gilmartin Capital, Intuitive Surgical, Inc.
and Apple Tree Partners. As of September 2025, the company is led by CEO Doug Godshall. Galvanize Therapeutics' primary product is the Aliya pulsed electric field system to enhance treatment efficacy in oncology and other therapeutic areas. The Aliya system is designed to provide a non-invasive approach for tissue ablation and modulation, improving patient outcomes in conditions such as non-small cell lung cancer (NSCLC) and chronic bronchitis.
The company's product portfolio includes the INUMI Flex Endoscopic Needle, which is used in conjunction with the Aliya system for soft tissue ablation. The company will use the September 2025 funding to enhance the development of its oncology and medical solutions.
Current Investors
Apple Tree Partners, Fidelity Investments, Intuitive Surgical, Inc.
Primary Industry
Medical Devices & Equipment
Sub Industries
Biotechnology, Oncology/Cancer Treatment, Therapeutic Devices, Medical Software
Website
www.galvanizetx.com
Verticals
Manufacturing
Total Amount Raised
Subscriber access only
Galvanize Therapeutics, Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Announced | Energenx Medical | - | ||||||||
| Merger | Completed | Gala Therapeutics Inc., Galaxy Medical, Inc. | - |
Displaying 1 - 2 of 2
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.